The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine

BACKGROUND: A phase III trial demonstrated an overall survival advantage with the addition of vinflunine to best supportive care (BSC) in platinum-refractory advanced urothelial cancer. We subsequently examined the impact of an additional 2 years of survival follow-up and evaluated the influence of...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Harshman, L C, Fougeray, R, Choueiri, T K, Schutz, F A, Salhi, Y, Rosenberg, J E, Bellmunt, J
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2013
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3833211/
https://ncbi.nlm.nih.gov/pubmed/24129239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.617
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы